
Sarepta Therapeutics, Inc.
USD17.02
+0.17 (+1.01%)
CEO
Douglas S. Ingram
IPO Date
1997-06-04
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$16.89
Prev. Close
$16.85
Day Low
$16.44
Day High
$17.40
52W Low
$10.42
52W High
$25.32
Market Cap
$1.80B
Volume
3.74M
| 19 Mar 2026 |
| Oppenheimer |
| Outperform |
| Outperform |
| maintain |
| 13 Mar 2026 | Mizuho | Outperform | Outperform | maintain |
| 10 Mar 2026 | Citigroup | Sell | Sell | maintain |
| 2 Mar 2026 | HC Wainwright & Co. | Sell | Sell | maintain |
| 27 Feb 2026 | Wells Fargo | Overweight | Overweight | maintain |
| 27 Jan 2026 | HC Wainwright & Co. | Sell | Sell | maintain |
| 23 Jan 2026 | Wedbush | Outperform | Outperform | maintain |